Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × Levetiracetam × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Seizures 2 Brain Neoplasms 2 beta-Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Necrosis 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Influenza, Human 1 Hematologic Neoplasms 1 Glioma 1 Chromosome Aberrations 1 Chromosome 7, monosomy 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Magnetic Resonance Spectroscopy 20 Temozolomide 14 Radiotherapy 9 Specimen Handling 7 Radiation 6 Blood Specimen Collection 6 Bevacizumab 4 trametinib 3 pembrolizumab 3 Surgical Procedures, Operative 3 Nivolumab 3 Drug Therapy 3 Cyclophosphamide 3 Biopsy 3 vorasidenib 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 fluciclovine F-18 2 dabrafenib 2 X-Rays 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Magnetic Resonance Imaging 2 Infusions, Intravenous 2 Genetic Testing 2 Everolimus 2 Etoposide 2 Elasticity Imaging Techniques 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03048084 2025-02-04

STING

Leiden University Medical Center

Phase 4 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡